MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with R

Raltegravir

Raltegravir 25mg chewable tablets

Incompatible

Stability notes for Raltegravir 25mg chewable tablets

Formulation not suitable for use in MCAs. Very moisture sensitive medicine  Original packaging may contain desiccant   No stability data in MCAs available

Provenance

This recommendation is based on the products Isentress 25mg chewable tablets (Merck Sharp & Dohme (UK) Limited).

Supplier

Isentress 25mg chewable tablets (Merck Sharp & Dohme (UK) Ltd)

Raltegravir 100mg chewable tablets

Incompatible

Stability notes for Raltegravir 100mg chewable tablets

Formulation not suitable for use in MCAs. Very moisture sensitive medicine  Original packaging may contain desiccant   No stability data in MCAs available

Provenance

This recommendation is based on the products Isentress 100mg chewable tablets (Merck Sharp & Dohme (UK) Limited).

Supplier

Isentress 100mg chewable tablets (Merck Sharp & Dohme (UK) Ltd)

Raltegravir 400mg tablets

Use with caution

Stability notes for Raltegravir 400mg tablets

Store in airtight containers. Soluble in water.

Provenance

This compatibility recommendation is derived from Isentress 400mg tablets (Merck Sharp & Dohme (UK) Ltd).

Supplier

Isentress 400mg tablets (Merck Sharp & Dohme (UK) Ltd)

Raltegravir 600mg tablets

No stability information

Stability notes for Raltegravir 600mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Raltegravir 600mg tablets
Isentress 600mg tablets (Merck Sharp & Dohme (UK) Ltd)
Raltegravir 600mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Raltegravir 600mg tablets (Lupin Healthcare (UK) Ltd)
Raltegravir 600mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.